Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers

Summary

The goal is to establish the safety of administration of nasal foralumab to healthy volunteers in escalating doses to determine the dose at which immune effects are observed. Patients will receive doses for 5 consecutive days and have a follow-up period.

Timeline

Start

2018-11-12

Primary completion

2019-07-23

Completion

2020-11-09

Drugs

Indications

No indication recorded.